-
Connecting Patients with The Treatment They Need
Kavita Bhat, PhD, is the Vice President of Lab Operations at Myriad Neuroscience, a subsidiary of Myriad Genetics. In her role, Dr. Bhat works closely ... Read More -
ACLA Statement on President Biden’s Actions to Combat COVID-19
Washington, D.C. – Following President Biden’s actions announced today to combat the COVID-19 pandemic, ACLA President Julie Khani released the following statement: “We commend President Biden ... Read More -
Joint Letter on Cycle-Threshold Value Reporting
-
ACLA Statement on President-elect Biden’s American Rescue Plan
Washington, D.C. – In response to the release of President-elect Biden’s American Rescue Plan, ACLA President Julie Khani released the following statement: “ACLA members stand ready to ... Read More -
ACLA Statement on Year-End Funding Package
WASHINGTON, D.C. – As Congress nears a vote on year-end legislation to fund the government and support COVID-19 response efforts, ACLA President Julie Khani released the following ... Read More -
Multiplex Testing: An Important Tool To Counter the Spread of Flu and COVID-19
A key part of the country’s ability to track and stop the spread of this virus and other infectious diseases is the continued development and ... Read More -
ACLA Statement on COVID-19 Vaccine Approval
Washington, D.C. – Following the Food and Drug Administration’s (FDA) emergency use authorization (EUA) of a COVID-19 vaccine, ACLA President Julie Khani issued the following statement: “With ... Read More -
ACLA Letter on COVID Vaccine Distribution
-
ACLA Comments on Medicare and Medicaid Programs, Clinical Laboratory Improvement Amendments and Patient Protection and Affordable Care Act Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency [CMS-3401-IFC]
-
ACLA Comments on 2021 ONC Interoperability Standards Advisory (ISA)
